Does prolonged pretreatment with large doses of spironolactone hasten a recovery from juxtaglomerular-adrenal suppression in primary aldosteronism?
D000293:Adolescent; D000311:Adrenal Glands / Q000503:physiopathology; D000328:Adult; D001794:Blood Pressure; D002986:Clinical Trials as Topic; D004039:Diet, Sodium-Restricted; D005260:Female; D005665:Furosemide; D006706:Homeostasis; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy*; D007606:Juxtaglomerular Apparatus / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009318:Natriuresis; D011188:Potassium / Q000097:blood / Q000652:urine; D012083:Renin / Q000097:blood*; D012964:Sodium / Q000097:blood; D013148:Spironolactone / Q000008:administration & dosage*
D013148:Spironolactone; D005665:Furosemide; D012964:Sodium; D012083:Renin; D011188:Potassium